Serum antibodies to HTLV-I in human demyelinating disease

L. Epstein, B. Blumberg, J. Crowley, S. Komoly, J. Goudsmit, S. Cook, P. Dowling

Research output: Article

15 Citations (Scopus)


Serum HTLV-I antibodies were measured in 17 MS patients and 2 closely matched control groups by 2 different independent assays. A highly sensitive particle agglutination test was used to detect HTLV-I core protein antigens and an immunoblot assay with E. coli-expressed P21E transmembrane protein was employed to detect antibodies to HTLV-I envelope antigens. No serologic evidence of prior HTLV-I infection in our population of multiple sclerosis (MS) or Guillain-Barre Syndrome (GBS) patients was found.

Original languageEnglish
Pages (from-to)231-233
Number of pages3
JournalActa Neurologica Scandinavica
Issue number4
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Serum antibodies to HTLV-I in human demyelinating disease'. Together they form a unique fingerprint.

  • Cite this

    Epstein, L., Blumberg, B., Crowley, J., Komoly, S., Goudsmit, J., Cook, S., & Dowling, P. (1987). Serum antibodies to HTLV-I in human demyelinating disease. Acta Neurologica Scandinavica, 75(4), 231-233.